Facebook
X
LinkedIn
ForwardSeries date:
06/30/2025 - 7:30am to 12/31/2025 - 8:30am
COURSE DIRECTOR
Shaji Kumar, M.D. and Prashant Kapoor, M.D.
DESCRIPTION
These are weekly meetings done for the disease group members. During this meeting, we discuss patients, journal articles, and clinical trial protocols. We also develop treatment guidelines during the meeting. There are 6 meetings a month.
Shaji Kumar, M.D. and Prashant Kapoor, M.D.
DESCRIPTION
These are weekly meetings done for the disease group members. During this meeting, we discuss patients, journal articles, and clinical trial protocols. We also develop treatment guidelines during the meeting. There are 6 meetings a month.
This series is presented In-Person and Live-Streamed.
TARGET AUDIENCE
Allied health professionals, MD, Resident/Fellows, APP/NP, Nursing, PhD, Nursing, Pharmacists, students
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
TARGET AUDIENCE
Allied health professionals, MD, Resident/Fellows, APP/NP, Nursing, PhD, Nursing, Pharmacists, students
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
- Identify how to utilize the appropriate measures to risk-stratify patients with plasma cell disorders.
- Review the best use of various testing strategies to make the right diagnosis of plasma cell disorders.
- Define the treatment approaches that lead to the best outcomes for patients with plasma cell disorders.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CREDIT STATEMENT(S)
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. All who are in a position to control the content are required to disclose all financial relationships with any ineligible company. Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.
Listed below are individuals with control of the content of this program who have disclosed...
Relevant financial relationship(s) with ineligible companies:
Shaji Kumar, M.D. - Honoraria - 858 Therapeutics; AbbVie, Inc.; Alexion Pharmaceuticals, Inc.; Ascentage Parma; AstraZeneca Pharmaceuticals LP; Becton, Dickson and Company(BD); BeiGene; BioLineRx Ltd.; BMS Global, Inc.; CDR-Life AG; CellCentric Limited; Celltrion Healthcare Co., Ltd.; CVS Caremark; DAVA Oncology, LP; Dr. Reddy's Laboratories, Inc.; Engage Health Media; Genetech, Inc.; GlaxoSmithKline; Hoffman - La Roche, LTD; Huadong Medicine; Icon; Janssen Biotech, Inc.; Janssen Global Services, LLC; Janssen Pharmaceuticals, Inc.; Janssen Research & Development, LLC; Keosys; Legend Biotech USA Inc.; Moderna Therapeutics; Oliver Wyman; Oricell Therapeutics; Pathos; PER; Pfizer, Inc.; Poseida Therapeutics; Pro-Clin. Solutions LLC.; Regeneron Pharmaceuticals, Inc.; Sandoz Inc.; Sanofi Genzyme; Sanofi Oncology; Takeda Pharmaceuticals, Inc.; Telo Genomics Holdings Corp; Vial Health Technology Inc; Window Therapeutics Inc; Worldwide Clinical Trials
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. All who are in a position to control the content are required to disclose all financial relationships with any ineligible company. Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.
Listed below are individuals with control of the content of this program who have disclosed...
Relevant financial relationship(s) with ineligible companies:
Shaji Kumar, M.D. - Honoraria - 858 Therapeutics; AbbVie, Inc.; Alexion Pharmaceuticals, Inc.; Ascentage Parma; AstraZeneca Pharmaceuticals LP; Becton, Dickson and Company(BD); BeiGene; BioLineRx Ltd.; BMS Global, Inc.; CDR-Life AG; CellCentric Limited; Celltrion Healthcare Co., Ltd.; CVS Caremark; DAVA Oncology, LP; Dr. Reddy's Laboratories, Inc.; Engage Health Media; Genetech, Inc.; GlaxoSmithKline; Hoffman - La Roche, LTD; Huadong Medicine; Icon; Janssen Biotech, Inc.; Janssen Global Services, LLC; Janssen Pharmaceuticals, Inc.; Janssen Research & Development, LLC; Keosys; Legend Biotech USA Inc.; Moderna Therapeutics; Oliver Wyman; Oricell Therapeutics; Pathos; PER; Pfizer, Inc.; Poseida Therapeutics; Pro-Clin. Solutions LLC.; Regeneron Pharmaceuticals, Inc.; Sandoz Inc.; Sanofi Genzyme; Sanofi Oncology; Takeda Pharmaceuticals, Inc.; Telo Genomics Holdings Corp; Vial Health Technology Inc; Window Therapeutics Inc; Worldwide Clinical Trials
Prashant Kapoor, M.D. - Honoraria - AbbVie Inc.; Angitia; AstraZeneca Pharmaceuticals LP; BeiGene; BMS Global, Inc.; Casma Therapeutics; Cellectar Biosciences; CVS Caremark; Genentech, Inc.; Genzyme Corporation; Janssen Scientific Affairs, LLC; Keosys; Kite Pharma, Inc.; Mustang Bio; PER; PRECISIONheor; Sanofi Genzyme; Sanofi US Services, Inc.
All relevant financial relationships have been mitigated.
No relevant financial relationship(s) with ineligible companies:
Matthew Bass (Coordinator)
No relevant financial relationship(s) with ineligible companies:
Matthew Bass (Coordinator)
References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None
ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.
TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.
None
ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.
TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
QUESTIONS?
Contact Matthew Bass
QUESTIONS?
Contact Matthew Bass
Where did the idea for the course originate?:
Minnesota